| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $709K | -42.0% |
| Cost of Revenue | $488K | -32.7% |
| Gross Profit | $221K | -55.5% |
| R&D Expense | $9.1M | -3.2% |
| SG&A Expense | $11.4M | +40.4% |
| Operating Income | -$21.0M | -16.5% |
| Income Tax | $0 | — |
| Net Income | -$21.4M | -13.7% |
| EPS (Basic) | -$1.02 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.9M | -52.9% |
| Short-term Investments | $412K | -95.5% |
| Accounts Receivable | $111K | -49.1% |
| Current Assets | $5.8M | -71.2% |
| Total Assets | $12.1M | -55.9% |
| Current Liabilities | $3.9M | -20.1% |
| Total Liabilities | $5.3M | -22.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.0M | -36.0% |
| Capital Expenditures | $301K | -47.1% |
| Investing Cash Flow | $8.2M | +1309.2% |
| Financing Cash Flow | $5.3M | +1133.8% |
| Free Cash Flow | -$19.3M | -32.8% |
| -13.3% |
| EPS (Diluted) | -$1.02 | -13.3% |
| Stockholders' Equity |
| $6.7M |
| -67.1% |